FDA Requests Public Input for National Antimicrobial Resistance Monitoring System 2026-2030 Strategic Plan
Jan. 13, 2025
According to a Jan. 8 announcement, the FDA has released a request for comments (RFC) soliciting public input on new opportunities and emergent monitoring needs for possible inclusion in the forthcoming National Antimicrobial Resistance Monitoring System (NARMS) 2026-2030 Strategic Plan.
The announcement said, “NARMS is a collaborative program of state and local public health departments and universities, the FDA, the Centers for Disease Control and Prevention (CDC), and the U.S. Department of Agriculture (USDA). This national public health surveillance system tracks changes in the antimicrobial susceptibility of enteric (intestinal) bacteria found in ill people (CDC), retail meats (FDA), and food animals (USDA) in the United States.”
The comment period for this RFC opens on January 10, and will be open for 75 days, ending on March 26.
Janette Wider is Editor-in-Chief for Healthcare Purchasing News.
